MIRA INFORM REPORT

 

 

Report Date :

07.05.2012

 

IDENTIFICATION DETAILS

 

Name :

TIPHARCO PHARMACEUTICAL JOINT STOCK COMPANY

 

 

Registered Office :

No. 15, Doc Binh Kieu Ward 2, My Tho City, Tien Giang Province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2011

 

 

Year of Establishment :

1976

 

 

Com. Reg. No.:

1200100557

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture and trading medical products and pharmaceutical products

 

 

No. of Employees :

340

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but Correct 

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Vietnam

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


SUBJECT IDENTIFICATION & LEGAL FORM

 

Current legal status

Registered English Name

 

TIPHARCO PHARMACEUTICAL JOINT STOCK COMPANY

Registered Vietnamese Name

 

CONG TY CO PHAN DUOC PHAM TIPHARCO

Trade name

 

TIPHARCO

Type of Business

 

Joint stock company

Year Established

 

1976

Establishment Decision

 

4905/QD-UBND

Date of Issuance

 

22 Jul 2005

Place of Issuance

 

People Committee of Tien Giang Province

Business Registration No.

 

1200100557

Date of Registration

 

06 Aug 2011

Place of Registration

 

Tien Giang Department of Planning and Investment

Current registered capital

 

VND 15,000,000,000

Status

 

Unlisted

Tax code

 

1200100557

Total Employees

 

340

 

Historical Identification & Legal form

List

Changed Items

Date of changes

1

Subject has got former Business Registration No: 5303000050

Changed to: 1200100557

06 Aug 2011

2

Subject has got former Board Of Director: Ms. TRAN THI THU PHONG - the former General Director

Changed to: Mr. PHAM QUANG BINH - the current General Director

01 Jun 2010

3

Subject has got former Business Registration No: 101228 issued on December 11th, 2000 Changed to: 5303000050

28 Feb 2006

4

Subject has got former Registered English Name: TIEN GIANG PHARMACEUTICAL AND MEDICAL EQUIPMENT COMPANY Changed to: TIPHARCO PHARMACEUTICAL JOINT STOCK COMPANY

01 Feb 2006

5

Subject has got former Registered Vietnamese Name: CONG TY DUOC VA VAT TU Y TE TIEN GIANG

Changed to: CONG TY CO PHAN DUOC PHAM TIPHARCO

01 Feb 2006

6

Subject has got former Type of Business: State owned company Changed to: Joint stock company

01 Feb 2006

7

Subject has got former Tax code No: 1200440715

Changed to: 1200100557

N/A

 

 

 

company ADDRESSES

 

Head Office

Address

 

No. 15, Doc Binh Kieu Ward 2, My Tho City, Tien Giang Province, Vietnam

Telephone

 

(84-73) 3871817/ 3872972

Fax

 

(84-73) 3885040

Email

 

tipharco@vnn.vn  or tipharco@pmail.vnn.vn

Website

 

http://www.tipharco.com.vn

 

Branch in Ho Chi Minh

Address

 

L3 - No. 131/1 To Hien Thanh Street - Ward 15, Ho Chi Minh City, Vietnam

Telephone

 

(84-8) 38644521

 

 

DIRECTORS

 

1. NAME

 

Mr. PHAM QUANG BINH

Position

 

General Director & Chairman

Date of Birth

 

06 Jun 1954

ID Number/Passport

 

310663953

ID Issue Date

 

08 Sep 2006

ID Issue Place

 

Tien Giang Police Dept

Resident

 

No. 1/12, Hoc Lac Street Ward 8, My Tho City, Tien Giang Province, Vietnam

Current resident

 

No. 1/12, Hoc Lac Street Ward 8, My Tho City, Tien Giang Province, Vietnam

Nationality

 

Vietnamese

 

2. NAME

 

Ms. TRAN THI TAM

Position

 

Deputy General Director

Current resident

 

No. 15 Doc Binh Kieu Street, Ward 2, My Tho City, Tien Giang Province, Vietnam

Nationality

 

Vietnamese

 

3. NAME

 

Mr. LE VAN CHAU

Position

 

Deputy General Director and Chief Accountant

Current resident

 

No.2/6C, Ly Thuong Kiet Street Ward 6, My Tho City, Tien Giang Province, Vietnam

Nationality

 

Vietnamese

 

BUSINESS NATURE AND ACTIVITIES

 

- Manufacture and trading medical products and pharmaceutical products.
- Import materials for pharmaceutical production, medical chemistry, packaging and pharmaceutical products.
- Processing, franchise and agent for trading pharmaceutical products.

 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

·         Types of products

 

Material and Complete pharmaceutical products

·         Market

 

China, France, Italy, India, Australia

·         Mode of payment

 

TT, DP, LC

 

EXPORT:

Note: Currently, the subject does not export.

 

 

 

BANKERS

 

1. BANK FOR INVESTMENT AND DEVELOPMENT OF VIETNAM TIEN GIANG BRANCH

Address

 

No.208A Nam Ky Khoi Nghia Street, My Tho City, Tien Giang Province, Vietnam

Telephone

 

(84-73) 3877559

 

2. VIET NAM JOINT STOCK COMMERCIAL BANK FOR INDUSTRY AND TRADE TIEN GIANG BRANCH

Address

 

No.15B Nam Ky Khoi Nghia Street, My Tho City, Tien Giang Province, Vietnam

Telephone

 

(84-73) 3872429/3872456

Fax

 

(84-73) 3872429

 

 

SHAREHOLDERS

 

Following is the list of the company’s shareholders updated to 31 Dec 2011.

1. NAME

 

THE STATE

Value of shares

 

0

Percentage

 

0%

 

2. NAME

 

PHAM TRUNG NGHIA

Nationality

 

Vietnamese

Value of shares

 

VND 3,400,000,000

Percentage

 

23%

 

3. NAME

 

NGUYEN VAN TAM

Nationality

 

Vietnamese

Value of shares

 

VND 4,260,000,000

Percentage

 

28%

 

4. NAME

 

HUYNH THI NGUYEN THUY

Nationality

 

Vietnamese

Value of shares

 

VND 3,797,330,000

Percentage

 

25%

 

5. NAME

 

OTHER SHAREHOLDERS

Value of shares

 

VND 3,542,670,000

Percentage

 

24%

 

 


FINANCIAL DATA

 

BALANCE SHEET

Unit: One VND

Balance sheet date

31/12/2011

31/12/2010

31/12/2009

Number of weeks

52

52

52

Status

Audited

Audited

Audited

ASSETS

A – CURRENT ASSETS

70,502,882,439

62,773,320,730

56,885,669,495

I. Cash and cash equivalents

10,955,616,843

6,450,130,165

5,994,750,008

1. Cash

10,955,616,843

2,450,130,165

5,994,750,008

2. Cash equivalents

0

4,000,000,000

0

II. Short-term investments

0

0

0

1. Short-term investments

0

0

0

2. Provisions for devaluation of short-term investments

0

0

0

III. Accounts receivable

22,633,610,208

23,001,494,501

13,640,398,974

1. Receivable from customers

22,229,039,207

20,411,003,643

12,439,485,184

2. Prepayments to suppliers

694,421,000

2,678,172,790

1,208,008,738

3. Inter-company receivable

0

0

0

4. Receivable according to the progress of construction

0

0

0

5. Other receivable

0

14,754,392

27,861,052

6. Provisions for bad debts

-289,849,999

-102,436,324

-34,956,000

IV. Inventories

36,656,061,371

33,233,074,938

36,987,467,522

1. Inventories

36,656,061,371

33,233,074,938

36,987,467,522

2. Provisions for devaluation of inventories

0

0

0

V. Other Current Assets

257,594,017

88,621,126

263,052,991

1. Short-term prepaid expenses

55,000,000

20,378,489

32,857,876

2. VAT to be deducted

106,362,263

0

102,545,718

3. Taxes and other accounts receivable from the State

27,989,117

0

0

4. Other current assets

68,242,637

68,242,637

127,649,397

B. LONG-TERM ASSETS

26,774,724,312

28,432,474,796

30,975,243,703

I. Long term accounts receivable

0

0

0

1. Long term account receivable from customers

0

0

0

2. Working capital in affiliates

0

0

0

3. Long-term inter-company receivable

0

0

0

4. Other long-term receivable

0

0

0

5. Provisions for bad debts from customers

0

0

0

II. Fixed assets

26,757,547,007

28,432,474,796

30,955,243,703

1. Tangible assets

26,107,356,078

27,753,654,703

30,247,794,446

- Historical costs

51,419,335,336

50,174,106,518

49,638,586,024

- Accumulated depreciation

-25,311,979,258

-22,420,451,815

-19,390,791,578

2. Financial leasehold assets

0

0

0

- Historical costs

0

0

0

- Accumulated depreciation

0

0

0

3. Intangible assets

650,190,929

678,820,093

707,449,257

- Initial costs

807,729,733

807,729,733

807,729,733

- Accumulated amortization

-157,538,804

-128,909,640

-100,280,476

4. Construction-in-progress

0

0

0

III. Investment property

0

0

0

Historical costs

0

0

0

Accumulated depreciation

0

0

0

IV. Long-term investments

0

0

20,000,000

1. Investments in affiliates

0

0

0

2. Investments in business concerns and joint ventures

0

0

0

3. Other long-term investments

0

0

20,000,000

4. Provisions for devaluation of long-term investments

0

0

0

V. Other long-term assets

17,177,305

0

0

1. Long-term prepaid expenses

17,177,305

0

0

2. Deferred income tax assets

0

0

0

3. Other long-term assets

0

0

0

VI. Goodwill

0

0

0

1. Goodwill

0

0

0

TOTAL ASSETS

97,277,606,751

91,205,795,526

87,860,913,198

 

LIABILITIES

A- LIABILITIES

69,891,344,239

66,258,870,475

66,080,610,827

I. Current liabilities

66,182,364,819

61,190,917,446

59,552,577,680

1. Short-term debts and loans

32,671,335,189

28,965,056,137

26,492,498,882

2. Payable to suppliers

24,941,598,942

26,278,275,956

25,942,627,685

3. Advances from customers

3,892,329,735

2,884,875,529

6,196,286,047

4. Taxes and other obligations to the State Budget

738,148,450

436,583,350

642,198,495

5. Payable to employees

3,615,147,784

2,260,508,558

0

6. Accrued expenses

0

0

0

7. Inter-company payable

0

24,476,428

0

8. Payable according to the progress of construction contracts

0

341,141,488

0

9. Other payable

323,804,719

0

278,966,571

10. Provisions for short-term accounts payable

0

0

0

II. Long-Term Liabilities

3,708,979,420

5,067,953,029

6,528,033,147

1. Long-term accounts payable to suppliers

0

0

0

2. Long-term inter-company payable

0

0

0

3. Other long-term payable

0

0

0

4. Long-term debts and loans

3,708,979,420

5,067,953,029

6,451,831,467

5. Deferred income tax payable

0

0

0

6. Provisions for unemployment allowances

0

0

76,201,680

7. Provisions for long-term accounts payable

0

0

0

B- OWNER’S EQUITY

27,386,262,512

24,946,925,051

21,780,302,371

I. OWNER’S EQUITY

27,325,779,178

24,946,925,051

21,298,754,864

1. Capital

15,000,000,000

15,000,000,000

15,000,000,000

2. Share premiums

0

0

0

3. Other sources of capital

0

0

0

4. Treasury stocks

0

-720,000,000

-720,000,000

5. Differences on asset revaluation

0

0

0

6. Foreign exchange differences

-248,235,682

0

0

7. Business promotion fund

6,320,713,376

5,049,044,813

3,691,300,551

8. Financial reserved fund

1,883,391,415

1,490,188,513

1,139,537,463

9. Other funds

0

 

0

10. Retained earnings

4,369,910,069

4,127,691,725

2,187,916,850

11. Construction investment fund

0

0

0

II. Other sources and funds

60,483,334

0

481,547,507

1. Bonus and welfare funds

60,483,334

0

481,547,507

2. Sources of expenditure

0

0

0

3. Fund to form fixed assets

0

0

0

MINORITY’S INTEREST

0

0

0

TOTAL LIABILITIES AND OWNER’S EQUITY

97,277,606,751

91,205,795,526

87,860,913,198

 

 

PROFIT & LOSS STATEMENT

 

Description

FY2011

FY2010

FY2009

1. Total Sales

214,140,275,388

205,384,615,374

192,678,242,599

2. Deduction item

1,341,005,658

728,387,474

364,603,931

3. Net sale

212,799,269,730

204,656,227,900

192,313,638,668

4. Costs of goods sold

182,841,513,002

178,707,528,058

168,950,882,389

5. Gross profit

29,957,756,728

25,948,699,842

23,362,756,279

6. Financial income

94,867,216

132,937,615

33,094,767

7. Financial expenses

4,782,375,337

4,819,856,472

3,676,554,038

- In which: Loan interest expenses

4,686,113,606

4,227,822,899

2,478,844,576

8. Selling expenses

10,953,576,466

13,544,376,616

12,863,741,930

9. Administrative overheads

9,881,909,391

3,463,154,090

2,498,805,852

10. Net operating profit

4,434,762,750

4,254,250,279

4,356,749,226

11. Other income

916,712,954

715,036,526

332,598,103

12. Other expenses

177,014,976

0

0

13. Other profit /(loss)

739,697,978

715,036,526

332,598,103

14. Total accounting profit before tax

5,174,460,728

4,969,286,805

4,689,347,329

15. Current corporate income tax

450,579,730

518,610,988

413,992,891

16. Deferred corporate income tax

0

0

0

17. Interest from subsidiaries/related companies

0

0

0

18. Profit after tax

4,723,880,998

4,450,675,817

4,275,354,438

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

 

Description

FY2011

FY2010

FY2009

Average Industry

Current liquidity ratio

1.07

1.03

0.96

1.65

Quick liquidity ratio

0.51

0.48

0.33

1.04

Inventory circle

4.99

5.09

4.48

4.14

Average receive period

38.82

41.02

25.89

105.37

Utilizing asset performance

2.19

2.24

2.19

1.20

Liability by total assets

71.85

72.65

75.21

53.11

Liability by owner's equity

255.21

265.60

303.40

159.74

Ebit / Total assets (ROA)

10.14

10.08

8.16

10.37

Ebit / Owner's equity (ROE)

36.01

36.87

32.91

23.03

Ebit / Total sale (NPM)

4.60

4.48

3.72

10.15

Gross profit / Total sale (GPM)

13.99

12.63

12.13

25.88

Note: The Average Industry was calculated by VietnamCredit based on our own statistical data

 

 

CASH FLOW STATEMENT

(Direct method)

Items

FY2011

FY2010

FY2009

I. Cash flows from operating activities

1.Cash received from customers

152,926,353,662

149,743,103,748

151,801,052,999

2. Cash paid to suppliers

-130,610,177,355

-134,907,239,144

-137,303,228,076

3. Cash paid to employees

-8,870,041,759

-9,047,685,847

-9,175,337,986

4. Interest paid

-4,645,224,237

-4,227,822,899

-2,478,844,576

5. Income taxes paid

-141,875,000

-710,073,410

-331,963,457

6. Other operating cash receipts

2,682,603,354

57,406,700

1,341,974,349

7. Other operating payments

-6,255,093,353

-484,821,079

-930,663,333

Net cash flows from operating activities

5,086,545,312

422,868,069

2,922,989,920

II. Cash flows from investing activities

1. Purchases and construction of fixed assets and other long-term assets

-1,320,052,609

-535,520,494

-7,433,630,509

2. Gains from disposals and liquidation of fixed assets and other long-term assets

101,974,636

0

0

3. Loans given and purchases of debt instruments of other entities

0

0

0

4. Recovery of loans given and disposals of debt instruments of other entities

0

20,000,000

0

5. Investments into other entities

0

0

0

6. Withdrawals of investments in other entities

0

0

0

7. Receipts of loan interests, dividends and profit shared

81,000,776

132,937,615

33,094,767

Net cash flows from investing activities

-1,137,077,197

-382,582,879

-7,400,535,742

III. Cash flows from financing activities

1. Gains from stock issuance and capital contributions from shareholders

720,000,000

0

0

2. Repayment for capital contributions and re-purchases of stocks already issues

0

0

0

3. Short-term and long-term loans received

70,309,663,760

61,931,495,802

91,421,353,334

4. Loan principal amounts repaid

-68,182,858,317

-60,842,816,985

-83,497,295,007

5. Payments for financial leasehold assets

0

0

0

6. Dividends and profit already paid to the owners

-2,193,097,850

-673,583,850

-1,258,670,000

Net cash flows from financing activities

653,707,593

415,094,967

6,665,388,327

Net cash flows during the year

4,603,175,708

455,380,157

2,187,842,505

Beginning cash and cash equivalents

6,450,130,165

5,994,750,008

3,806,907,503

Effects of fluctuations in foreign exchange rates

-97,689,030

0

0

Ending cash and cash equivalents

10,955,616,843

6,450,130,165

5,994,750,008

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Good

Liquidity

 

Medium

Payment status

 

Average

Financial Situation

 

Above Average

Development trend

 

Positive

Litigation data

 

No Record

Bankruptcy

 

No Record

Payment Methods

 

TT, L/C, DP

Sale Methods

 

Retailer and Wholesaler

Public opinion

 

Excellent

 

 

CREDIT INQUIRY: USD 125,000 against DA in terms

Acceptable!

 

 

INTERPRETATION ON THE SCORES

 

The subject was originally established in 1976 as a state owned company. In 2006, the subject was capitalized and its name also changed to Tipharco Pharmaceutical Joint Stock Company. Currently, the subject is operating under the business registration No. 1200100557 issued by Tien Giang Department of Planning and Investment. It has registered capital of VND 15 billion.

The company is specialized in manufacturing, trading, importing medicine, cosmetic, hygienic products, nutritive products, other pharmaceutical products, health service equipments and material.

Its head office and factory are located at No. 15, Doc Binh Kieu Street, Ward 2, My Tho City, Tien Giang Province. Currently, it produces more than 140 types of drugs and trading more than 4,500 types of drugs. The subject also built the agent system in Tien Giang Province and Mekong Delta area. Its products are consumed in many provinces, both in the North and the South of Viet Nam.

The company’s financial situation seems fairly good and stable. In 2011, the value of the company’s total assets was VND 97.3 billion. According to the balance sheet, current assets always took higher rate in the company’s total assets and account receivable and inventories were two items has highest proportion in current assets. According to the financial ratio table, the company’s operational ratios are fairly good. Inventory circle was above average industry and average receivable period was shorter than average industry. The company managed inventories and account receivable quite effectively. According to the financial ratio table, the company’s liability by total assets was still bigger than average industry. But it had down compared to previous year. The subject has tended to reduce the reliance on external financial resources. However, this process still happened with low speed. The profitability of the subject is average. In 2011, the subject attained VND 214 billion of total sales and it made a profit of VND 4.7 billion; higher than previous year.

In general, the subject is a medium sized company in the industry. The production activities and trading activities of the subject are busy. It is reliable for all small financial commitments.

 

APPENDIX

 

INDUSTRY DATA

 

Industry code

Growth speed by price compared with 1994 (%)

Total enterprises 2009

Total employees 2010

(Thous.pers.)

Annual average capital of enterprises 2009

(billion dongs)

2011

2010

Agriculture, Forestry and Fishing

4.00

2.78

8,749

23,896.3

81,559

Industry and Construction

5.53

7.70

85,115

10,630

2,751,975

Trade and Services

6.69

7.52

154,978

14,522

4,939,069

 

ECONOMIC INDICATORS

 

 

2011 

2010 

2009 

Population (Million person)

87.84

86.93

86.02

Gross Domestic Products (USD billion)

119

102.2

91

GDP Growth (%)

5.89

6.78

5.32

GDP Per Capita (USD/person/year)

1,300

1,160

1,080

Inflation (% Change in Composite CPI)

18.58

11.75

6.88

State Budget Deficit compared with GDP (%)

4.9

5.8

6.9

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2011 

2010 

2009 

Exports

96.3

72.2

57.1

Imports

105.8

84.8

69.9

Trade Balance

-9.5

-12.6

-12.8

Source: General Statistics Office


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.72

UK Pound

1

Rs.86.98

Euro

1

Rs.70.65

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.